Found 6 matching trials
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
PHASE1This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
PHASE2RATIONALE: Vaccines made from melanoma cells may make the body build an imm...
Location
USC/Norris Comprehensive Cancer Center and Hospital
Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
PHASE1RATIONALE: Biological therapies such as flt3L and CD40-ligand use different...
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
PHASE1RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Location
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
PHASE2The primary goal of this Phase I/II study is to assess the immune response ...
Location
National Institute of Allergy and Infectious Diseases (NIAID)
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
PHASE1This is a multipart, open-label, multi-center dose escalation, dose expansi...
Location
Moffitt Cancer Center